Human responses against HER-2-positive cancer cells in human immune system-engrafted mice

British Journal of Cancer

Volumn 107, Issue 8, 2012, Pages 1302-1309

  De Giovanni, C ^a   Nicoletti, G ^b   Landuzzi, L ^b   Romani, F ^c   Croci, S ^d   Palladini, A ^a   Murgo, A ^a   Antognoli, A ^a   Ianzano, M L ^a   Stivani, V ^a   Grosso, V ^a   Iezzi, M ^d   Stramucci, L ^d   Barbieri, E ^a   Lemoli, R M ^a   Nanni, P ^a   Lollini, P L ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d UNIVERSITY OF CHIETI   (Italy)

Author keywords

Cancer vaccine; Hematopoietic stem cells; HER 2; Human immune system mice; IL 12; Metastasis

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; GAMMA INTERFERON; IMMUNOGLOBULIN G; RAG2 PROTEIN; RECOMBINANT INTERLEUKIN 12; TUMOR CELL VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CANCER CELL; CANCER IMMUNOLOGY; CANCER INFILTRATION; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DENDRITIC CELL; ENGRAFTMENT; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LUNG METASTASIS; LYMPHOID ORGAN; MOUSE; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; CANCER VACCINES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GLYCOPROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN ISOTYPES; LUNG NEOPLASMS; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PEPTIDES; RECEPTOR, ERBB-2;

EID: 84867399067     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.394     Document Type: Article

References (36)

1. Becker PD, Legrand N, van Geelen CM, Noerder M, Huntington ND, Lim A, Yasuda E, Diehl SA, Scheeren FA, Ott M, Weijer K, Wedemeyer H, Di Santo JP, Beaumont T, Guzman CA, Spits H (2010) Generation of human antigen-specific monoclonal IgM antibodies using vaccinated 'human immune system' mice. PLoS One 5(10): e13137
2. Bornhauser M, Eger L, Oelschlaegel U, Auffermann-Gretzinger S, Kiani A, Schetelig J, Illmer T, Schaich M, Corbeil D, Thiede C, Ehninger G (2005) Rapid reconstitution of dendritic cells after allogeneic transplantation of CD133+ selected hematopoietic stem cells. Leukemia 19(1): 161-165 (Pubitemid 40090099)
3. Brehm MA, Shultz LD, Greiner DL (2010) Humanized mouse models to study human diseases. Curr Opin Endocrinol Diabetes Obes 17(2): 120-125
4. Cavallo F, De Giovanni C, Nanni P, Forni G, Lollini PL (2011) 2011: the immune hallmarks of cancer. Cancer Immunol Immunother 60(3): 319-326
5. De Giovanni C, Nicoletti G, Palladini A, Croci S, Landuzzi L, Antognoli A, Murgo A, Astolfi A, Ferrini S, Fabbi M, Orengo AM, Amici A, Penichet ML, Aurisicchio L, Iezzi M, Musiani P, Nanni P, Lollini PL (2009) A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome. Hum Gene Ther 20(5): 453-464
6. Dienz O, Rincon M (2009) The effects of IL-6 on CD4 T cell responses. Clin Immunol 130(1): 27-33
7. Drake AC, Khoury M, Leskov I, Iliopoulou BP, Fragoso M, Lodish H, Chen J (2011) Human CD34 CD133 hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NODSCID Il2rgamma (NSG) mice. PLoS One 6(4): e18382
8. Gorantla S, Sneller H, Walters L, Sharp JG, Pirruccello SJ, West JT, Wood C, Dewhurst S, Gendelman HE, Poluektova L (2007) Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice. J Virol 81(6): 2700-2712
9. Huntington ND, Di Santo JP (2008) Humanized immune system (HIS) mice as a tool to study human NK cell development. Curr Top Microbiol Immunol 324: 109-124
10. Kametani Y, Shiina M, Katano I, Ito R, Ando K, Toyama K, Tsukamoto H, Matsumura T, Saito Y, Ishikawa D, Taki T, Ito M, Imai K, Tokuda Y, Kato S, Tamaoki N, Habu S (2006) Development of human-human hybridoma from anti-Her-2 peptide-producing B cells in immunized NOG mouse. Exp Hematol 34(9): 1240-1248
11. Keyes KA, Mann L, Teicher B, Alvarez E (2003) Site-dependent angiogenic cytokine production in human tumor xenografts. Cytokine 21(2): 98-104 (Pubitemid 36369396)
12. Koo GC, Hasan A, O'Reilly RJ (2009) Use of humanized severe combined immunodeficient mice for human vaccine development. Expert Rev Vaccines 8(1): 113-120
13. Kuruvilla JG, Troyer RM, Devi S, Akkina R (2007) Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice. Virology 369(1): 143-152
14. Kwant-Mitchell A, Ashkar AA, Rosenthal KL (2009a) Mucosal innate and adaptive immune responses against herpes simplex virus type 2 in a humanized mouse model. J Virol 83(20): 10664-10676
15. Kwant-Mitchell A, Pek EA, Rosenthal KL, Ashkar AA (2009b) Development of functional human NK cells in an immunodeficient mouse model with the ability to provide protection against tumor challenge. PLoS One 4(12): e8379
16. Legrand N, Ploss A, Balling R, Becker PD, Borsotti C, Brezillon N, Debarry J, de Jong Y, Deng H, Di Santo JP, Eisenbarth S, Eynon E, Flavell RA, Guzman CA, Huntington ND, Kremsdorf D, Manns MP, Manz MG, Mention JJ, Ott M, Rathinam C, Rice CM, Rongvaux A, Stevens S, Spits H, Strick-Marchand H, Takizawa H, van Lent AU, Wang C, Weijer K, Willinger T, Ziegler P (2009) Humanized mice for modeling human infectious disease: challenges, progress, and outlook. Cell Host Microbe 6(1): 5-9
17. Lollini PL, Nicoletti G, Landuzzi L, Cavallo F, Forni G, De Giovanni C, Nanni P (2011) Vaccines and other immunological approaches for cancer immunoprevention. Curr Drug Targets 12(13): 1957-1973
18. Manz MG (2007) Human-hemato-lymphoid-system mice: opportunities and challenges. Immunity 26(5): 537-541 (Pubitemid 46756351)
19. Manz MG, Di Santo JP (2009) Renaissance for mouse models of human hematopoiesis and immunobiology. Nat Immunol 10(10): 1039-1042
20. Meek B, Cloosen S, Borsotti C, Van Elssen CH, Vanderlocht J, Schnijderberg MC, van der Poel MW, Leewis B, Hesselink R, Manz MG, Katsura Y, Kawamoto H, Germeraad WT, Bos GM (2010) In vitrodifferentiated T/natural killer-cell progenitors derived from human CD34+ cells mature in the thymus. Blood 115(2): 261-264
21. Melani C, Pupa SM, Stoppacciaro A, Menard S, Colnaghi MI, Parmiani G, Colombo MP (1995) An in vivo model to compare human leukocyte infiltration in carcinoma xenografts producing different chemokines. Int J Cancer 62(5): 572-578
22. Nanni P, Nicoletti G, De Giovanni C, Landuzzi L, Di Carlo E, Cavallo F, Pupa SM, Rossi I, Colombo MP, Ricci C, Astolfi A, Musiani P, Forni G, Lollini PL (2001) Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice. J Exp Med 194(9): 1195-1205 (Pubitemid 33055039)
23. Nanni P, Nicoletti G, Landuzzi L, Croci S, Murgo A, Palladini A, Antognoli A, Ianzano ML, Stivani V, Grosso V, Maira SM, Garcia-Echeverria C, Scotlandi K, De Giovanni C, Lollini PL (2010) High metastatic efficiency of human sarcoma cells in Rag2/gammac double knockout mice provides a powerful test system for antimetastatic targeted therapy. Eur J Cancer 46(3): 659-668
24. Nanni P, Nicoletti G, Palladini A, Croci S, Murgo A, Antognoli A, Landuzzi L, Fabbi M, Ferrini S, Musiani P, Iezzi M, De Giovanni C, Lollini PL (2007) Antimetastatic activity of a preventive cancer vaccine. Cancer Res 67(22): 11037-11044 (Pubitemid 350145934)
25. Nomura T, Tamaoki N, Takakura A, Suemizu H (2008) Basic concept of development and practical application of animal models for human diseases. Curr Top Microbiol Immunol 324: 1-24
26. Ross JS, Slodkowska EA, Symmans WF, Pusztai L, Ravdin PM, Hortobagyi GN (2009) The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine. Oncologist 14(4): 320-368
27. Rossi L, Manfredini R, Bertolini F, Ferrari D, Fogli M, Zini R, Salati S, Salvestrini V, Gulinelli S, Adinolfi E, Ferrari S, Di Virgilio F, Baccarani M, Lemoli RM (2007) The extracellular nucleotide UTP is a potent inducer of hematopoietic stem cell migration. Blood 109(2): 533-542 (Pubitemid 46105950)
28. Shultz LD, Ishikawa F, Greiner DL (2007) Humanized mice in translational biomedical research. Nat Rev Immunol 7(2): 118-130 (Pubitemid 46174859)
29. Strowig T, Gurer C, Ploss A, Liu YF, Arrey F, Sashihara J, Koo G, Rice CM, Young JW, Chadburn A, Cohen JI, Munz C (2009) Priming of protective T cell responses against virus-induced tumors in mice with human immune system components. J Exp Med 206(6): 1423-1434
30. Talukder AH, Bagheri-Yarmand R, Williams RR, Ragoussis J, Kumar R, Raz A (2002) Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors. Clin Cancer Res 8(10): 3285-3289 (Pubitemid 35155042)
31. Thiel U, Pirson S, Muller-Spahn C, Conrad H, Busch DH, Bernhard H, Burdach S, Richter GH (2011) Specific recognition and inhibition of Ewing tumour growth by antigen-specific allo-restricted cytotoxic T cells. Br J Cancer 104(6): 948-956
32. Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304(5667): 104-107 (Pubitemid 38451466)
33. Wang Y, Niu XL, Qu Y, Wu J, Zhu YQ, Sun WJ, Li LZ (2010) Autocrine production of interleukin-6 confers cisplatin and paclitaxel resistance in ovarian cancer cells. Cancer Lett 295(1): 110-123
34. Wege AK, Ernst W, Eckl J, Frankenberger B, Vollmann-Zwerenz A, Mannel DN, Ortmann O, Kroemer A, Brockhoff G (2011) Humanized tumor mice - a new model to study and manipulate the immune response in advanced cancer therapy. Int J Cancer 129(9): 2194-2206
35. Wei WZ, Jacob J, Radkevich-Brown O, Whittington P, Kong YC (2008) The 'A, B and C' of Her-2 DNA vaccine development. Cancer Immunol Immunother 57(11): 1711-1717
36. Yokotsuka M, Iwaya K, Saito T, Pandiella A, Tsuboi R, Kohno N, Matsubara O, Mukai K (2011) Overexpression of HER2 signaling to WAVE2-Arp2/3 complex activates MMP-independent migration in breast cancer. Breast Cancer Res Treat 126(2): 311-318